ArticlePolymers2025
Modulated Degradation of Polylactic Acid Electrospun Coating on WE43 Stents.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Magnesium-based coronary stents have gained significant interest due to their excellent biocompatibility, biodegradability, and mechanical properties. However, a key limitation of magnesium in biomedical applications is its low corrosion resistance, which compromises its structural integrity and mechanical strength over time. Polymeric coatings can overcome this challenge, enhancing magnesium-based implants' corrosion resistance and overall performance. This study applied a polylactic acid (PLA) nanofiber coating to WE43 magnesium (Mg) stents via electrospinning to reduce their corrosion rate. Both uncoated and coated stents underwent in vitro immersion tests in Hank's solution for 1, 3, 7, and 14 days. The effectiveness of the PLA coating was evaluated through morphological analysis, chemical composition assessment, corrosion behavior (weight change), magnesium ion release, and in vitro biocompatibility. The corrosion observed in the uncoated WE43 stents indicates that protective coatings are necessary to regulate degradation rates over extended implantation periods. The results demonstrated that coated stents exhibited improved performance, maintaining the integrity of the PLA coating for up to 14 days. The coated stents demonstrated reduced surface damage and lower weight loss resulting from lower magnesium release. In our study, the coated stents demonstrated a reduced corrosion rate (0.216 ± 0.013 mm/year) compared with the uncoated stents (0.312 ± 0.010 mm/year), both after 14 days. Additionally, in vitro biocompatibility results confirmed the non-toxic nature of PLA-coated stents, which enhances cellular proliferation and contributes to a more favorable environment for vascular healing. These findings suggest that PLA coatings can effectively prolong the functional durability of WE43 Mg stents, offering a promising solution for enhancing the performance of biodegradable stents in cardiovascular applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.